Detecting Melanoma Cells in Blood
In Vivo Real-time Detection of Circulating Melanoma Cells
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 75 (estimated)
- Sponsor
- University of Arkansas · Other
This trial is looking for melanoma patients to see if a new device can detect cancer cells in their blood. Participants will need to sit still for 90 minutes during the test.
You may be able to join if
- I am between 18 and 80 years old.
- I have a diagnosed case of melanoma.
- I can provide a signed consent form.
- I can sit still for 90 minutes.
You may not be able to join if
- I have an active infection.
- I have a serious medical condition.
- I have been diagnosed with organic brain syndrome.
- I am pregnant or breastfeeding.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.
Loading trial locations…